Publications
134
Citations
2,068
Est. group size
~9
Recurring co-author estimate
Active years
19
Publishing since 2008
Jennifer A. Sinnott's work focuses on cancer epidemiology and biostatistics, particularly studying molecular and genetic factors linked to prostate cancer progression and mortality, such as gene expression signatures, cholesterol metabolism, and genetic risk variants. Her research also extends to other cancers (colorectal, lung, endometrial/cervical) and disease burden studies, often applying statistical and bioinformatic methods to large patient cohorts and genomic datasets. This work is relevant to students interested in combining data analysis with clinical cancer research to understand disease risk and outcomes.
Publication output has grown substantially over the last decade, with a notable surge in 2023 following relatively steady, modest activity in earlier years.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Assessment of disability and disease burden in neuromyelitis optica spectrum disorders in the CIRCLES Cohort
Scientific Reports · 2024
- Association of Telomere Length with Colorectal Cancer Risk and Prognosis: A Systematic Review and Meta-Analysis
Cancers · 2023
- Real-world comparison of survival outcomes with cisplatin versus carboplatin in patients with limited-stage small-cell lung cancer
Cancer Treatment and Research Communications · 2023
- Data from Stress-Related Signaling Pathways in Lethal and Nonlethal Prostate Cancer
2023
- Data from Cholesterol Metabolism and Prostate Cancer Lethality
2023
- Supplementary Table 1 from Cholesterol Metabolism and Prostate Cancer Lethality
2023
- Supplementary Figure 1 from Cholesterol Metabolism and Prostate Cancer Lethality
2023
- Supplementary Data from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary figure legend from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary Figure 2 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary Figure 1 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary Figure 4 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary Figure 3 from Prognostic Utility of a New mRNA Expression Signature of Gleason Score
2023
- Supplementary Tables 1-4 from Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue
2023
- Supplementary Figures from Association of Prostate Cancer Risk Variants with Gene Expression in Normal and Tumor Tissue
2023
- Gynecologic Oncology×12
- Cancer Research×5
- Cancer Epidemiology Biomarkers & Prevention×4
- Neurology×4
- European Urology×3
- Dinuka De Silva
Medicine · Indiana University
- Pete E. Pascuzzi
Medicine · Purdue University West Lafayette
- John D. Graham
Medicine · Indiana University
- Ashorne K. Mahenthiran
Medicine · Indiana University
- Kathleen Kelly
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile